Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfectionYixian Zhang, Ivan D. Horak|Gene Therapy|2010Cited by 67
Combination therapy for treating breast cancer using antiestrogen, ERA-923, and the mammalian target of rapamycin inhibitor, temsirolimusTyler Sadler, Yixian Zhang|Endocrine Related Cancer|2006Cited by 38